Myo-Inositol CEST (MICEST) studies have shown that in an APP/PS1 mouse model of advanced AD the MICEST contrast is twice that of healthy brain, which corresponds to ~50% increase in mIns/Cr assessed using MRS [151]. This evidence concerns the gene APP and Alzheimer disease.